Active Biotech AB (ACTI) — Cash Flow Reinvestment Rate
Latest as of June 2019:
0.00x
Active Biotech AB (ACTI) has a Cash Flow Reinvestment Rate of 0.00x as of June 2019, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr262.60 Million. Explore ACTI capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr262.60 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Active Biotech AB (None–None)
Year-by-year capital reinvestment analysis for Active Biotech AB. For live market cap and broader valuation context, see Active Biotech AB (ACTI) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow